Catalyst Wire Dossier Catalyst Wire Dossier

BAY1002670 (Vilaprisan)

Vilaprisan · Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY1002670 (Vilaprisan), covering 2017-08-18 to 2017-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) [Phase 1]

See pricing